Immune checkpoint inhibitors in challenging populations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint inhibitors in challenging populations

Published:2017-02-27 Issue:11 Volume:123 Page:1904-1911
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Johnson Douglas B.¹^ORCID,Sullivan Ryan J.²,Menzies Alexander M.³

Affiliation:

1. Department of Medicine; Vanderbilt University Medical Center; Nashville Tennessee

2. Department of Medicine; Massachusetts General Hospital; Boston Massachusetts

3. Department of Medicine; Melanoma Institute Australia, University of Sydney Royal North Shore and Mater Hospitals; Sydney New South Wales Australia

Funder

National Cancer Institute

Cancer Institute NSW

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.30642/fullpdf

Reference75 articles.

1. PD-1 blockers;Wolchok;Cell.,2015

2. Fulminant myocarditis with combination immune checkpoint blockade;Johnson;N Engl J Med.,2016

3. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4;Waterhouse;Science.,1995

4. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans;Prokunina;Nat Genet.,2002

5. Induction of autoimmune disease by deletion of CTLA-4 in mice in adulthood;Klocke;Proc Natl Acad Sci U S A.,2016

Cited by 280 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Risk Non-Melanoma Skin Cancers;Hematology/Oncology Clinics of North America;2024-10

2. Cancer immunotherapy and its facilitation by nanomedicine;Biomarker Research;2024-08-03

3. 81-Year-Old Woman With Hemoptysis;Mayo Clinic Proceedings;2024-07

4. Pembrolizumab in an HIV-infected patient with glioblastoma;Immunotherapy;2024-06-18

5. A Cuproptosis-Related gene Signature as a Prognostic Biomarker in Thyroid Cancer Based on Transcriptomics;Biochemical Genetics;2024-04-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3